GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

polfurmetinib   Click here for help

GtoPdb Ligand ID: 14063

Synonyms: Example 69 [WO2022208391A1]
Compound class: Synthetic organic
Comment: Polfurmetinib is the INN for a MEK tyrosine kinase inhibitor with antineoplastic potential, from INN proposed list 133 (10th July 2025). The structure is claimed as Example 69 in Pfizer patent WO2022208391A1 [1]. Pfizer have a brain-penetrant MEK inhibitor (PF-07799544) in clinical development, but its structure has not been disclosed (August 2025).
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 2
Rotatable bonds 6
Topological polar surface area 107.41
Molecular weight 393.43
XLogP 0.13
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CN1C(=O)C=C2CCN(C(=O)C2=C1NC3=CC=C(C=C3F)SC)OCCO
Isomeric SMILES CN1C(=O)C=C2CCN(C(=O)C2=C1NC3=C(C=C(C=C3)SC)F)OCCO
InChI InChI=1S/C18H20FN3O4S/c1-21-15(24)9-11-5-6-22(26-8-7-23)18(25)16(11)17(21)20-14-4-3-12(27-2)10-13(14)19/h3-4,9-10,20,23H,5-8H2,1-2H3
InChI Key TURWFFGYNJNSFK-UHFFFAOYSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

Bioactivity Comments
Inhibits phosphorylation of downstream ERK1/2 in A375 cells (IC50 2 nM) [1]. Inhibitory potencies for polfurmetinib at MEK isozymes are not provided in the patent.